We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

422 hedge funds and large institutions have $5.25B invested in Viking Therapeutics in 2024 Q3 according to their latest regulatory filings, with 94 funds opening new positions, 179 increasing their positions, 101 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more call options, than puts

Call options by funds: $464M | Put options by funds: $242M

77% more repeat investments, than reductions

Existing positions increased: 179 | Existing positions reduced: 101

65% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 57

33% more funds holding in top 10

Funds holding in top 10: 6 → 8 (+2)

23% more capital invested

Capital invested by funds: $4.26B → $5.25B (+$987M)

9% more funds holding

Funds holding: 387 → 422 (+35)

2.82% more ownership

Funds ownership: 72.94% → 75.76% (+2.8%)

Holders
422
Holders Change
+35
Holders Change %
+9.04%
% of All Funds
6.06%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
94
Increased
179
Reduced
101
Closed
57
Calls
$464M
Puts
$242M
Net Calls
+$222M
Net Calls Change
-$14.8M

Top Buyers

1
Norges Bank
Norges Bank
Norway
+$63.8M
2
Citadel Advisors
Citadel Advisors
Florida
+$59M
3
IAIM
International Assets Investment Management
Florida
+$58.4M
4
PA
Perceptive Advisors
New York
+$57.4M
5
Morgan Stanley
Morgan Stanley
New York
+$54.4M

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$53.8M
2
BlackRock
BlackRock
New York
-$37.9M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$37.1M
4
Millennium Management
Millennium Management
New York
-$32.3M
5
State Street
State Street
Massachusetts
-$26.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
126
Prudential Financial
New Jersey
$3.08M -$1.11M -18,846 -28%
PM
127
Prosight Management
Texas
$3.04M -$3.93M -67,000 -58%
PA
128
Profund Advisors
Maryland
$3.04M -$680K -11,587 -19%
FMI
129
F/M Investments
District of Columbia
$3.02M +$407K +6,933 +17%
LCG
130
Lisanti Capital Growth
New York
$2.97M +$368K +6,270 +15%
KI
131
Keystone Investors
Singapore
$2.96M -$2.65M -45,205 -49%
FCI
132
Financial Counselors Inc
Kansas
$2.91M +$2.7M +45,981 New
Treasurer of the State of North Carolina
133
Treasurer of the State of North Carolina
North Carolina
$2.91M +$11.1K +190 +0.4%
EAM
134
Erste Asset Management
Austria
$2.9M +$939K +16,000 +52%
Janus Henderson Group
135
Janus Henderson Group
United Kingdom
$2.89M – – –
Ohio Public Employees Retirement System (OPERS)
136
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.86M +$302K +5,155 +13%
EHI
137
Eagle Health Investments
Connecticut
$2.85M – – –
JAM
138
JW Asset Management
Florida
$2.85M +$2.64M +45,000 New
Cambridge Investment Research Advisors
139
Cambridge Investment Research Advisors
Iowa
$2.68M +$1.01M +17,261 +69%
KCM
140
Kennedy Capital Management
Missouri
$2.66M -$295K -5,025 -11%
SCM
141
Sterling Capital Management
North Carolina
$2.56M +$2.37M +40,363 New
TAM
142
Titleist Asset Management
Texas
$2.53M -$1.17M -20,022 -33%
ACH
143
ArrowMark Colorado Holdings
Colorado
$2.53M – – –
DMKJ
144
David M. Knott Jr
$2.47M -$2.17M -37,000 -49%
ACA
145
Aptus Capital Advisors
Alabama
$2.41M +$569K +9,699 +34%
SLC
146
Second Line Capital
Louisiana
$2.41M +$569K +9,699 +34%
NSEDCP
147
NJ State Employees Deferred Compensation Plan
New Jersey
$2.41M – – –
State of New Jersey Common Pension Fund D
148
State of New Jersey Common Pension Fund D
New Jersey
$2.38M – – –
SEI Investments
149
SEI Investments
Pennsylvania
$2.34M +$354K +6,040 +20%
CIP
150
Chartwell Investment Partners
Pennsylvania
$2.32M +$1.01M +17,159 +88%
4 5
6
7 8

VKTX Hedge Fund Activity: Q3 2024 in Review

422 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q3 2024, worth a combined $5.25B — up 23% from $4.26B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new VKTX positions and 57 closed out — a net gain of 37 holders — while 179 added to existing stakes and 101 trimmed.

The largest buyer was Norges Bank, adding an estimated $63.8M. The largest seller was Goldman Sachs, cutting an estimated $53.8M.

  • 422 institutional investors held Viking Therapeutics (VKTX) as of Q3 2024, up from 387 in Q2 2024.
  • Funds reported $5.25B of Viking Therapeutics stock for Q3 2024, up 23% quarter-over-quarter.
  • 94 funds opened new Viking Therapeutics positions in Q3 2024 and 57 closed out, a net change of +37 holders.
  • The largest Viking Therapeutics buyer in Q3 2024 was Norges Bank, an estimated $63.8M added.
  • The largest Viking Therapeutics seller in Q3 2024 was Goldman Sachs, an estimated $53.8M sold.

Based on aggregated 13F filings for Q3 2024.